Evaluation of interleukin-2 administered
Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma
β
Sewa S. Legha; Mary Ann Gianan; Carl Plager; Omar E. Eton; Nicholas E. J. Papado
π
Article
π
1996
π
John Wiley and Sons
π
English
β 726 KB
## BACKGROUND. Interleukin-2 (IL-2) has been used widely in the treatment of advanced melanoma, most often using a high dose bolus schedule of administration. We have evaluated the antitumor activity and toxicity of IL-2 when administered by a continuous infusion schedule in patients with metastat